Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.58 |
| ▸ | LMNA | P02545 | 2/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.58 |
| ▸ | USP2 | O75604 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | CASP1 | P29466 | 1/20 | 0.58 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.58 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.58 |
| ▸ | THRB | P10828 | 2/20 | 0.49 |
| ▸ | THRA | P10827 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 3/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.48 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.48 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7892842 | 1.00 | MEN1 (0.58) | MEN1KMT2ALMNACYP3A4ALDH1A1 | |
| SCHEMBL10414494 | 1.00 | MEN1 (0.58) | MEN1KMT2ALMNACYP3A4ALDH1A1 | |
| SCHEMBL6855044 | 1.00 | MEN1 (0.58) | MEN1KMT2ALMNACYP3A4ALDH1A1 | |
| SCHEMBL7263986 | 1.00 | MEN1 (0.58) | MEN1KMT2ALMNACYP3A4ALDH1A1 | |
| SCHEMBL1741013 | 1.00 | MEN1 (0.58) | MEN1KMT2ALMNACYP3A4ALDH1A1 | |
| SCHEMBL11002455 | 1.00 | MEN1 (0.58) | MEN1KMT2ALMNACYP3A4ALDH1A1 | |
| SCHEMBL10581916 | 1.00 | MEN1 (0.58) | MEN1KMT2ALMNACYP3A4ALDH1A1 | |
| SCHEMBL5145456 | 1.00 | MEN1 (0.58) | MEN1KMT2ALMNACYP3A4ALDH1A1 | |
| SCHEMBL542332 | 1.00 | MEN1 (0.58) | MEN1KMT2ALMNACYP3A4ALDH1A1 | |
| SCHEMBL905495 | 1.00 | MEN1 (0.58) | MEN1KMT2ALMNACYP3A4ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5357636-A | Flexible protective medical gloves and methods for their use | DRESDNER JR KARL P (US) | 1994-10-25 | — | — | US | claimed |
| US-5335373-A | Protective medical gloves and methods for their use | DRESDNER JR KARL P (US) | 1994-08-09 | — | — | US | claimed |
| US-4329146-A | Process for the dyeing of fibre material | CIBA-GEIGY CORPORATION (US) | 1982-05-11 | — | — | US | claimed |
| EP-2099485-B1 | ALPHAVIRUS AND ALPHAVIRUS REPLICON PARTICLE FORMULATIONS AND METHODS | ALPHAVAX INC (US) | 2018-03-21 | — | — | EP | disclosed |
| US-9187729-B2 | Alphavirus and alphavirus replicon particle formulations and methods | ALPHAVAX, INC. (US) | 2015-11-17 | — | — | US | disclosed |
| US-20110182941-A1 | Alphavirus and Alphavirus Replicon Particle Formulations and Methods | ALPHAVAX, INC. (US) | 2011-07-28 | — | — | US | disclosed |
| US-20090047255-A1 | Alphavirus and Alphavirus Replicon Particle Formulations and Methods | ALPHAVAX, INC. (US) | 2009-02-19 | — | — | US | disclosed |
| US-20070042030-A1 | Preparation for the application of agents in mini-droplets | IDEA AG (DE) | 2007-02-22 | — | — | US | disclosed |
| EP-0475160-B2 | Preparation for drug application in minute droplet form | IDEA AG (DE) | 2004-07-14 | — | — | EP | disclosed |
| US-20020169138-A1 | Delivery vehicles for bioactive agents and uses thereof | SOUTHERN RESEARCH INSTITUTE | 2002-11-14 | — | — | US | disclosed |
| US-6165500-A | Preparation for the application of agents in mini-droplets | IDEA AG (DE) | 2000-12-26 | — | — | US | disclosed |
| WO-1996032124-A1 | MODIFIED LYSINE OR ARGININE CONTAINING PROTEINS AND PEPTIDES | NEW YORK BLOOD CENTER (US) | 1996-10-17 | — | — | WO | disclosed |
| EP-0475160-B1 | Preparation for drug application in minute droplet form | IDEA AG (DE) | 1996-02-14 | — | — | EP | disclosed |
| WO-1995018970-A1 | RADIAL FLOW ASSAY | INTRACEL CORPORATION (US) | 1995-07-13 | — | — | WO | disclosed |
| US-5384128-A | Method of and compounds for treatment for cystic fibrosis | UNIVERSITY OF ALABAMA RESEARCH FOUNDATION (US) | 1995-01-24 | — | — | US | disclosed |
| US-5357636-A | Flexible protective medical gloves and methods for their use | DRESDNER JR KARL P (US) | 1994-10-25 | — | — | US | disclosed |
| US-5335373-A | Protective medical gloves and methods for their use | DRESDNER JR KARL P (US) | 1994-08-09 | — | — | US | disclosed |
| EP-0475160-A1 | Preparation for drug application in minute droplet form | Cevc, Gregor, Prof. Dr. (DE) | 1992-03-18 | — | — | EP | disclosed |
| WO-1992003122-A1 | PREPARATION FOR APPLICATION OF ACTIVE SUBSTANCES IN THE FORM OF MINIMUM-SIZED DROPLETS | CEVC GREGOR (DE) | 1992-03-05 | — | — | WO | disclosed |
| US-4329146-A | Process for the dyeing of fibre material | CIBA-GEIGY CORPORATION (US) | 1982-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070042030-A1 | Preparation for the application of agents in mini-droplets | FABP4, NPC1L1, LIPA | MEN1 1210/4885KMT2A 4875/4885LMNA 327/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.